FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

410861007: Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3677285011 Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3677286012 Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2466312019 Carbidopa 12.5mg/levodopa 50mg/entacapone 200mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2472512016 Carbidopa 12.5mg/levodopa 50mg/entacapone 200mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2478140014 Levodopa 50mg/carbidopa 12.5mg/entacapone 200mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3486785018 Product containing carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3495134012 Product containing carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501954013 Carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569996017 Product containing only carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569997014 Product containing only carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3677285011 Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3677286012 Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3677287015 Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Is a Carbidopa+levodopa+entacapone false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Entacapone (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levodopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbidopa false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Levodopa (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Entacapone (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Entacapone (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Entacapone (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Carbidopa true Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value 12.5 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levodopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Levodopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbidopa false Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Carbidopa false Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value 12.5 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient Carbidopa true Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Is a Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient Entacapone (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient Levodopa (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Is a Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Plays role Antiparkinson therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start